Cargando...
Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects
Pancreatic ductal adenocarcinoma (PDAC) is projected to emerge as the second leading cause of cancer-related death after 2030. Extreme treatment resistance is perhaps the most significant factor that underlies the poor prognosis of PDAC. To date, combination chemotherapy remains the mainstay of trea...
Guardado en:
| Publicado en: | World J Gastroenterol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8117738/ https://ncbi.nlm.nih.gov/pubmed/34025067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i18.2105 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|